SARS-CoV-2感染与急性后期精神及神经系统诊断风险:一项丹麦全国性队列研究
该丹麦全国队列纳入2020年3月1日全国12岁及以上人群共3,239,008人,随访至2023年1月31日。SARS-CoV-2阳性者急性后期任何精神疾病风险降低24%(IRR 0.76,95%CI 0.74-0.78),任何神经系统疾病风险略高(IRR 1.05,95%CI 1.04-1.07),住院COVID-19患者风险显著升高。
要点
- SARS-CoV-2阳性者急性后期任何精神疾病风险较非阳性者降低24%(IRR 0.76,95%CI 0.74-0.78)。
- SARS-CoV-2阳性者任何神经系统疾病风险略高于非阳性者(IRR 1.05,95%CI 1.04-1.07)。
- 住院COVID-19患者精神疾病风险为非阳性者2.1倍(IRR 2.05,95%CI 1.78-2.37),神经系统疾病风险为2.4倍(IRR 2.44,95%CI 2.29-2.60)。
核心结论
- 本研究不支持SARS-CoV-2感染者普通人群中存在大量急性后期神经和精神疾病负担的既往发现,但证实最严重COVID-19病例风险升高。
研究设计与样本
- 丹麦全国性队列研究,纳入2020年3月1日丹麦全国12岁及以上人群共3,239,008人,随访至2023年1月31日。
- 主要关注期为感染后1-12个月,比较SARS-CoV-2阳性者与非阳性者11种精神疾病和30种神经疾病新发发病率。
主要发现
- 随访期间队列中1,775,639人SARS-CoV-2检测阳性。
- SARS-CoV-2阳性者较非阳性者急性后期任何精神疾病风险降低24%(IRR 0.76,95%CI 0.74-0.78)。
- SARS-CoV-2阳性者任何神经系统疾病风险略高于非阳性者(IRR 1.05,95%CI 1.04-1.07)。
- 特定疾病IRR差异大,从嗅觉或味觉改变风险增加3.9倍(IRR 3.91,95%CI 2.77-5.53)到痴呆风险降低29%(IRR 0.71,95%CI 0.65-0.78)。
- 住院COVID-19患者较非阳性者精神疾病风险增加2.1倍(IRR 2.05,95%CI 1.78-2.37),神经系统疾病风险增加2.4倍(IRR 2.44,95%CI 2.29-2.60)。
关键数值与推荐
- 感染严重程度和疫苗接种状态较年龄、性别和变异株更显著影响分层IRR。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The extent and burden of postacute psychiatric and neurologic manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not yet fully understood. To evaluate the association between SARS-CoV-2 infection and postacute manifestations of psychiatric and neurologic disorders, we conducted a nationwide cohort study including the entire Danish population aged 12 years or older on March 1, 2020. METHODS: Individuals were followed up for SARS-CoV-2 infection and diagnosis of subsequent psychiatric and neurologic disorders from March 1, 2020, to January 31, 2023, using the Danish nationwide coronavirus disease 2019 (COVID-19) test surveillance database and the Danish National Patient Registry. The main period of interest was 1-12 months after infection. Incidence rate ratios (IRRs) of new onset of 11 psychiatric and 30 neurologic disorders were calculated by comparing incidence rates of disorders between SARS-CoV-2-positive individuals and individuals without a positive test (nonpositive individuals). Stratified analyses were conducted according to COVID-19 vaccination status, variant period, age, sex, and severity of infection. RESULTS: Overall, 1,775,639 individuals in the study cohort (n = 3,239,008) were tested SARS-CoV-2 positive during follow-up. SARS-CoV-2-positive individuals compared with nonpositive individuals were at 24% reduced risk of any psychiatric disease (IRR 0.76, 95% CI 0.74-0.78) in the postacute period. The risk of any neurologic disorder was slightly higher among SARS-CoV-2-positive individuals than among those without a positive test (IRR 1.05, 95% CI 1.04-1.07). IRRs for specific disorders varied considerably from a 3.9-fold increased risk of change in sense of smell or taste (IRR 3.91, 95% CI 2.77-5.53) to a 29% reduced risk of dementia (IRR 0.71, 95% CI 0.65-0.78). The severity of infection and vaccination status, more so than age, sex, and variant, were found to significantly influence the stratified IRRs. Compared with nonpositive individuals, hospitalized patients with COVID-19 were at a 2.1-fold (IRR 2.05, 95% CI 1.78-2.37) increased risk of psychiatric disorders and at a 2.4-fold increased risk of neurologic disorders (IRR 2.44, 95% CI 2.29-2.60). DISCUSSION: Our study does not support previous findings of substantial postacute neurologic and psychiatric morbidities among the general population of SARS-CoV-2-infected individuals, but does corroborate an elevated risk among the most severe cases with COVID-19.
引用
- Nielsen NM, Spiliopoulos L, Hansen JV, et al. SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study. Neurology. 2024. PMID: 38382013. doi:10.1212/WNL.0000000000208113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。